argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus

Go back to argenx Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus
(NASDAQ: ARGX) Delayed: 1007.07 -26.08 (2.52%)
Previous Close $1033.15    52 Week High
Open $1005.68    52 Week Low
Day High $1015.79    P/E N/A 
Day Low $995.00    EPS
Volume 313,873       

(NASDAQ: ARGX) Delayed: 1007.07 -26.08 (2.52%)
Previous Close $1033.15    52 Week High
Open $1005.68    52 Week Low
Day High $1015.79    P/E N/A 
Day Low $995.00    EPS
Volume 313,873